195 related articles for article (PubMed ID: 11249773)
1. Gene therapy: a molecular approach to cancer treatment.
Anklesaria P
Curr Opin Mol Ther; 2000 Aug; 2(4):426-32. PubMed ID: 11249773
[TBL] [Abstract][Full Text] [Related]
2. Technology evaluation: tgDCC-E1A, targeted genetics/MD Anderson.
Wagner JA
Curr Opin Mol Ther; 1999 Apr; 1(2):266-70. PubMed ID: 11715950
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
4. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
Liao Y; Zou YY; Xia WY; Hung MC
Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
[TBL] [Abstract][Full Text] [Related]
5. [Molecular therapy for human cancer with tumor suppressor p53 gene transfer].
Fujiwara T; Inoue F; Tanaka N
Gan To Kagaku Ryoho; 1998 Jan; 25(2):194-200. PubMed ID: 9474928
[TBL] [Abstract][Full Text] [Related]
6. Safety study and characterization of E1A-liposome complex gene-delivery protocol in an ovarian cancer model.
Xing X; Zhang S; Chang JY; Tucker SD; Chen H; Huang L; Hung MC
Gene Ther; 1998 Nov; 5(11):1538-44. PubMed ID: 9930307
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for lung cancer: practice and promise.
Vattemi E; Claudio PP
Ann Ital Chir; 2004; 75(3):279-89. PubMed ID: 15605515
[TBL] [Abstract][Full Text] [Related]
8. Current status of gene therapy for lung cancer and head and neck cancer.
Moon C; Oh Y; Roth JA
Clin Cancer Res; 2003 Nov; 9(14):5055-67. PubMed ID: 14613982
[TBL] [Abstract][Full Text] [Related]
9. Restoration of tumour suppressor gene expression for cancer.
Roth JA
Forum (Genova); 1998; 8(4):368-76. PubMed ID: 9863031
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer.
Yoo GH; Hung MC; Lopez-Berestein G; LaFollette S; Ensley JF; Carey M; Batson E; Reynolds TC; Murray JL
Clin Cancer Res; 2001 May; 7(5):1237-45. PubMed ID: 11350889
[TBL] [Abstract][Full Text] [Related]
11. P53 tumor suppressor gene therapy for cancer.
Nielsen LL; Maneval DC
Cancer Gene Ther; 1998; 5(1):52-63. PubMed ID: 9476967
[TBL] [Abstract][Full Text] [Related]
12. [Adenoviral p53 gene therapy for human lung cancer].
Fujiwara T; Tanaka N
Gan To Kagaku Ryoho; 2003 Apr; 30(4):460-7. PubMed ID: 12722675
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
14. Non-viral gene delivery for p53.
Pirollo KF; Xu L; Chang EH
Curr Opin Mol Ther; 2000 Apr; 2(2):168-75. PubMed ID: 11249638
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
16. The current status of gene therapy.
Clayman GL
Semin Oncol; 2000 Aug; 27(4 Suppl 8):39-43. PubMed ID: 10952437
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral strategies for the gene therapy of cancer.
Relph KL; Harrington KJ; Pandha H
Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
[TBL] [Abstract][Full Text] [Related]
18. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
[TBL] [Abstract][Full Text] [Related]
19. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene.
Ueno NT; Bartholomeusz C; Xia W; Anklesaria P; Bruckheimer EM; Mebel E; Paul R; Li S; Yo GH; Huang L; Hung MC
Cancer Res; 2002 Nov; 62(22):6712-6. PubMed ID: 12438271
[TBL] [Abstract][Full Text] [Related]
20. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
Wiman KG
Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
